Today, the Controller of Iradimed Corp (NASDAQ: IRMD), Louis Waldman, sold shares of IRMD for $94.97K.
Following Louis Waldman’s last IRMD Sell transaction on March 19, 2018, the stock climbed by 3.7%. In addition to Louis Waldman, one other IRMD executive reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Iradimed Corp’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $7.11 million and quarterly net profit of $841.2K. In comparison, last year the company earned revenue of $5.16 million and had a GAAP net loss of $233.3K. IRMD’s market cap is $193.4M and the company has a P/E ratio of 131.43. Currently, Iradimed Corp has an average volume of 68.17K.
The insider sentiment on Iradimed Corp has been negative according to 23 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Louis Waldman’s trades have generated a 18.1% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
IRadimed Corp. engages in the development, manufacture, market, and distribution of magnetic resonance imaging compatible products and non-magnetic intravenous infusion pump systems for use by hospitals and acute care facilities. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
